A Novel Glucose-Sensitive Scaffold Accelerates Osteogenesis in Diabetic Conditions

Biomed Res Int. 2022 Mar 18:2022:4133562. doi: 10.1155/2022/4133562. eCollection 2022.

Abstract

Mandibular bone regeneration is still a big challenge in those diabetic patients with poorly controlled blood glucose. In this study, we prepared a novel glucose-sensitive controlled-release fiber scaffold (PVA-HTCC/PEO-rhBMP2-glucose oxidase (PHPB-G)), which contained the recombinant human bone morphogenetic protein 2 (rhBMP2) by coaxial cospinning and grafted with glucose oxidase (GOD). We presented evidence that PHPB-G could undergo a series of structural changes with the blood glucose and promoted bone regeneration in diabetic rat. PHPB-G expanded the voids in nanofibers when blood glucose levels elevated. More importantly, its slow-release rhBMP2 effectively promoted the healing of bone defects. These data suggested that the PHPB-G delivery system may provide a potential treatment strategy for patients with severe diabetic alveolar bone defects.

MeSH terms

  • Animals
  • Blood Glucose
  • Bone Morphogenetic Protein 2 / chemistry
  • Bone Morphogenetic Protein 2 / pharmacology
  • Bone Regeneration
  • Diabetes Mellitus*
  • Glucose / pharmacology
  • Glucose Oxidase / pharmacology
  • Humans
  • Osteogenesis*
  • Rats
  • Recombinant Proteins / pharmacology
  • Tissue Scaffolds / chemistry

Substances

  • Blood Glucose
  • Bone Morphogenetic Protein 2
  • Recombinant Proteins
  • Glucose Oxidase
  • Glucose